RecruitingNCT03190928

Clonal Evolution in Follicular Lymphoma

Prospective Study of Clonal Evolution in Follicular Lymphoma


Sponsor

National Cancer Institute (NCI)

Enrollment

200 participants

Start Date

Jul 27, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Follicular lymphoma is a type of cancer of the lymph nodes. Lab studies are important for cancer research. They help scientists better understand differences in the cancer biology of different patients. Researchers want to collect serial samples over time from people with follicular lymphoma to help them design future treatments. Objective: To collect a variety of samples from people with follicular lymphoma to study how these diseases progress and respond to treatment. Eligibility: Adults at least 18 years old who have been diagnosed with, but have not yet had any treatment for, follicular lymphoma. Design: Participants will be screened with medical history and physical exam. They will answer questions about daily functioning. They will have blood and urine tests. They may have scans and have tissue samples taken. Participants will be monitored about every 4 months for up to 2 years. They will repeat screening tests. They will have a cheek swab. A small brush will be rubbed against the inside of the cheek to wipe off some cells. Participants will have imaging scans about every 8 months for up to 2 years. Participants may have a bone marrow aspiration and biopsy. The hipbone will be numbed with a small needle. A needle will be put into the hipbone, and about 2 tablespoons of bone marrow will be taken out through the needle. Participants will continue being monitored every 6 months for up to 5 years, then 1 time a year. ...


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is researching how follicular lymphoma — a slow-growing blood cancer of the immune system — evolves and changes over time at the genetic level, and whether early treatment helps, by collecting samples and following patients over the long term. **You may be eligible if...** - You have a confirmed diagnosis of follicular lymphoma (grades 1, 2, or 3a), verified by the NCI Laboratory of Pathology - You have enough biopsy tissue available from your original diagnosis (or are willing to have a new biopsy if needed) - Your cancer has spread to different parts of your body (measurable disease in at least 2 areas) **You may NOT be eligible if...** - Your diagnosis cannot be confirmed with available tissue - A new biopsy would be considered too risky for you - You do not meet the other clinical eligibility criteria set by the study team Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03190928


Related Trials